American Portfolios Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$473K Buy
6,224
+314
+5% +$26K 0.02% 665
2022
Q2
$500K Sell
5,910
-155
-3% -$13.6K 0.02% 656
2022
Q1
$532K Buy
6,065
+75
+1% +$6.49K 0.02% 709
2021
Q4
$524K Sell
5,990
-109
-2% -$9.05K 0.02% 717
2021
Q3
$499K Sell
6,099
-516
-8% -$46.4K 0.02% 715
2021
Q2
$604K Sell
6,615
-377
-5% -$33.6K 0.02% 629
2021
Q1
$598K Buy
6,992
+651
+10% +$58.4K 0.03% 583
2020
Q4
$599K Sell
6,341
-419
-6% -$36.6K 0.03% 503
2020
Q3
$588K Buy
6,760
+205
+3% +$17.8K 0.03% 434
2020
Q2
$573K Buy
6,555
+331
+5% +$28.6K 0.04% 403
2020
Q1
$513K Sell
6,224
-813
-12% -$72.5K 0.04% 363
2019
Q4
$666K Buy
7,037
+130
+2% +$11.7K 0.05% 347
2019
Q3
$600K Buy
6,907
+128
+2% +$11.5K 0.05% 351
2019
Q2
$619K Sell
6,779
-705
-9% -$59.7K 0.05% 333
2019
Q1
$645K Buy
7,484
+651
+10% +$52.3K 0.06% 301
2018
Q4
$525K Sell
6,833
-623
-8% -$48.5K 0.06% 268
2018
Q3
$576K Sell
7,456
-661
-8% -$48.9K 0.07% 282
2018
Q2
$549K Buy
8,117
+1,501
+23% +$104K 0.07% 263
2018
Q1
$479K Buy
6,616
+28
+0.4% +$2.13K 0.07% 271
2017
Q4
$496K Buy
+6,588
New +$497K 0.08% 254

Other funds holding NVS

American Portfolios Advisors's NVS Position: Q3 2022 in Review

American Portfolios Advisors increased its Novartis (NVS) stake by 5.3% in Q3 2022, buying an estimated $26K and bringing the position to 6,224 shares worth $473K. The position accounts for 0.02% of the portfolio, ranked #665.

American Portfolios Advisors first reported a position in NVS in Q4 2017 and has held it in 20 quarters since. The position peaked at $666K in Q4 2019. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

  • American Portfolios Advisors held 6,224 shares of Novartis worth $473K as of Q3 2022.
  • American Portfolios Advisors bought 314 Novartis shares in Q3 2022, an estimated $26K.
  • Novartis made up 0.02% of American Portfolios Advisors's portfolio in Q3 2022, its #665 holding.
  • American Portfolios Advisors first reported a position in Novartis in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Novartis position peaked at $666K in Q4 2019.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.